First, VEGF-driven angiogenesis can lead to the expansion of tumor-suppressing immune cells (including Tregs and MDSCs) and increase the infiltration of tumor-associated macrophages (TAMs) in the tumor site (36–38). This evidence concerns the gene VEGFA and neoplasm.